Metabolism - Clinical and Experimental
Volume 55, Issue 3 , Pages 309-316 , March 2006

Effect of troglitazone on tumor necrosis factor α and transforming growth factor β expression and action in human adipocyte precursor cells in primary culture

Received 15 January 2005 ,Accepted 7 September 2005.

References 

  1. Iwamoto Y, Kuzuya T, Matsuda A, et al. Effects of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM. Diabetes Care. 1991;14:1083–1086
  2. Nolan JJ, Ludvik BL, Beerdsen P, et al. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med. 1994;331:1188–1193
  3. Saltiel AR, Olefsky JM. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes. 1996;45:1661–1669
  4. Lehmann JM, Moore LB, Smith-Oliver TA, et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator–activated receptor γ (PPARγ). J Biol Chem. 1995;270:12953–12956
  5. Spiegelman BM. PPARγ: adipogenic regulator and thiazolidinedione receptor. Diabetes. 1998;47:507–514
  6. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor–α: direct role in obesity-linked insulin resistance. Science. 1993;259:87–91
  7. Kern PA, Saghizadeh M, Ong JM, et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss and relationship to lipoprotein lipase. J Clin Invest. 1995;95:2111–2199
  8. Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose tissue expression of tumor necrosis factor–α in human obesity and insulin resistance. J Clin Invest. 1995;95:2409–2415
  9. Hube F, Birgel M, Lee Y-M, Hauner H. Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non–insulin-dependent diabetes mellitus. Eur J Clin Invest. 1999;29:672–678
  10. Hotamisligil GS, Spiegelman BM. TNF-α: a key component of the obesity-diabetes link. Diabetes. 1994;43:1271–1278
  11. Stephens JM, Pekala PH. Transcriptional repression of the GLUT4 and c/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor–α. J Biol Chem. 1991;266:21839–21845
  12. Stephens JM, Lee J, Pilch PF. Tumor necrosis factor-alpha–induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor–mediated signal transduction. J Biol Chem. 1997;272:971–976
  13. Feinstein R, Kanety H, Papa MZ, et al. Tumor necrosis factor–α suppresses insulin-induced tyrosine phosphorylation of the insulin receptor and its substrates. J Biol Chem. 1993;268:26055–26058
  14. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor–α inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A. 1994;91:4854–4858
  15. Kroder G, Bossenmayer B, Kellerer M, et al. Tumor necrosis factor–α and hyperglycemia-induced insulin resistance. J Clin Invest. 1996;97:1471–1477
  16. Liu LS, Spelleken M, Röhrig K, Hauner H, Eckel J. Tumor necrosis factor (TNF)–alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 TNF receptor. Diabetes. 1998;47:515–522
  17. Petruschke T, Hauner H. Tumor necrosis factor–alpha prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells. J Clin Endocrinol Metab. 1993;76:742–747
  18. Hauner H, Petruschke T, Russ M, Röhrig K, Eckel J. Effects of tumor necrosis factor alpha (TNF) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia. 1995;38:764–771
  19. Birgel M, Gottschling-Zeller H, Röhrig K, Hauner H. Role of cytokines in the regulation of plasminogen activator inhibitor–1 expression and secretion in newly differentiated subcutaneous human adipocytes. Arterioscler Thromb Vasc Biol. 2000;20:1682–1687
  20. Petruschke T, Röhrig K, Hauner H. Transforming growth factor beta (TGF-β) inhibits the differentiation of human adipocyte precursor cells in primary culture. Int J Obes. 1994;18:532–536
  21. Ohsumi J, Sakakibara S, Yamaguchi J, et al. Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells. Endocrinology. 1994;135:2279–2282
  22. Hofmann C, Lorenz K, Braithwait E, et al. Altered gene expression for tumor necrosis factor–α and its receptors during drug and dietary modulation of insulin resistance. Endocrinology. 1994;134:264–270
  23. Szalkowski D, White-Carrington S, Berger J, Zhang B. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor–alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology. 1995;136:1474–1481
  24. Hauner H, Skurk T, Wabitsch M. Culture of human adipose precursor cells. Methods Mol Biol. 2001;155:239–247
  25. Hauner H, Röhrig K, Spelleken M, Liu LS, Eckel J. Development of insulin-responsive glucose uptake and GLUT4 expression in differentiating human adipocytes precursor cells. Int J Obes. 1998;22:448–452
  26. Pairault J, Green H. A study of the adipose conversion of suspended 3T3 cells by using glycerophosphate dehydrogenase as differentiation marker. Proc Natl Acad Sci U S A. 1979;76:5138–5142
  27. Peterson GL. A simplification of the protein assay of Lowry et al. Which is more generally applicable?. Anal Biochem. 1977;83:346–356
  28. Hube H, Lee Y-M, Röhrig K, Hauner H. The phosphodiesterase inhibitor IBMX suppresses TNF-α expression in human adipocyte precursor cells: a possible explanation for its adipogenic effect. Horm Metab Res. 1999;31:359–362
  29. Kletzien RF, Clarke SD, Ulrich RG. Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Mol Pharmacol. 1992;41:393–399
  30. Sandouk T, Reda D, Hofmann C. Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am J Physiol. 1993;264:C1600–C1608
  31. Adams M, Montague CT, Prins JB, et al. Activators of peroxisome proliferator–activated receptor γ have depot-specific effects on human preadipocyte differentiation. J Clin Invest. 1997;100:3149–3153
  32. Halvorsen Y-DC, Bond A, Sen A, et al. Thiazolidinediones and glucocorticoids synergistically induce differentiation of human adipose tissue stromal cells: biochemical, cellular, and molecular analysis. Metabolism. 2001;50:407–413
  33. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998;391:82–86
  34. Swinburn BA, Nyomba BL, Saad MF, et al. Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest. 1991;88:168–173
  35. Parulkar AA, Pendergrass ML, Granda-Ayala R, Lee TR, Fonseca VA. Nonhypoglycemic effects of thiazolidinediones. Ann Intern Med. 2001;134:61–71

PII: S0026-0495(05)00360-4

doi: 10.1016/j.metabol.2005.09.004

Metabolism - Clinical and Experimental
Volume 55, Issue 3 , Pages 309-316 , March 2006

Article Tools

* Image Usage & Resolution